Výsledky vyhledávání - Lorinda Simms
- Zobrazuji výsledky 1 - 8 z 8
-
1
-
2
-
3
The Differential Efficacy of Pemetrexed According to NSCLC Histology: A Review of Two Phase III Studies Autor Giorgio V. Scagliotti, Nasser H. Hanna, Frank V. Fossella, Katherine P. Sugarman, J. Blatter, Patrick Peterson, Lorinda Simms, Frances A. Shepherd
Vydáno 2009Revisão -
4
Treatment-by-Histology Interaction Analyses in Three Phase III Trials Show Superiority of Pemetrexed in Nonsquamous Non-small Cell Lung Cancer Autor Giorgio V. Scagliotti, Thomas Brodowicz, Frances A. Shepherd, Christoph Zielinski, Johan Vansteenkiste, Christian Manegold, Lorinda Simms, Frank V. Fossella, Katherine P. Sugarman, Chandra P. Belani
Vydáno 2010Artigo -
5
Gemcitabine Plus Paclitaxel Versus Paclitaxel Monotherapy in Patients With Metastatic Breast Cancer and Prior Anthracycline Treatment Autor Kathy S. Albain, Shona Nag, G. Calderillo-Ruiz, Johann Petrus Jordaan, Antonio Llombart–Cussac, A Płużańska, Janusz Rolski, Allen S. Melemed, Jose M. Reyes-Vidal, Jagdev Singh Sekhon, Lorinda Simms, Joyce O’Shaughnessy
Vydáno 2008Artigo -
6
Phase III Study Comparing Cisplatin Plus Gemcitabine With Cisplatin Plus Pemetrexed in Chemotherapy-Naive Patients With Advanced-Stage Non–Small-Cell Lung Cancer Autor Giorgio V. Scagliotti, Purvish Parikh, Joachim von Pawel, Bonne Biesma, Johan Vansteenkiste, Christian Manegold, Piotr Serwatowski, U. Gatzemeier, Raghunadharao Digumarti, Mauro Zukin, Jin S. Lee, Anders Mellemgaard, Keunchil Park, Shehkar Patil, Janusz Rolski, Tuncay Göksel, Filippo de Marinis, Lorinda Simms, Katherine P. Sugarman, David R. Gandara
Vydáno 2008Artigo -
7
Primary Results of ROSE/TRIO-12, a Randomized Placebo-Controlled Phase III Trial Evaluating the Addition of Ramucirumab to First-Line Docetaxel Chemotherapy in Metastatic Breast Ca... Autor John R. Mackey, Manuel Ramos-Vázquez, O. N. Lipatov, Nicole McCarthy, Dmitriy Krasnozhon, Semiglazov Vf, Alexey Manikhas, Karen A. Gelmon, Gottfried E. Konecny, Marc Webster, Roberto Hegg, Sunil Verma, Vera Gorbunova, Dany Abi Gerges, Francois Thireau, Helena Fung, Lorinda Simms, Marc Buyse, Ayman Ibrahim, Miguel Martín
Vydáno 2014Artigo -
8
Phase I and Pharmacokinetic Study of Pemetrexed Administered Every 3 Weeks to Advanced Cancer Patients With Normal and Impaired Renal Function Autor Alain C. Mita, Christopher J. Sweeney, Sharyn D. Baker, Andrew Goetz, Lisa A. Hammond, Amita Patnaik, Anthony W. Tolcher, Miguel A. Villalona‐Calero, Alan Sandler, Tuhin K. Chaudhuri, Kathleen Molpus, Jane E. Latz, Lorinda Simms, Ajai K. Chaudhary, Robert D. Johnson, Eric K. Rowinsky, Chris H. Takimoto
Vydáno 2006Artigo
Vyhledávací nástroje:
Související témata
Internal medicine
Medicine
Oncology
Chemotherapy
Confidence interval
Hazard ratio
Cisplatin
Gemcitabine
Lung cancer
Pemetrexed
Docetaxel
Histology
Neutropenia
Breast cancer
Cancer
Clinical endpoint
Gastroenterology
Metastatic breast cancer
Pathology
Phases of clinical research
Proportional hazards model
Randomized controlled trial
Taxane
Alternative medicine
Anthracycline
Bioinformatics
Biology
Biostatistics
Botany
Clinical trial